Inventor
KATHLEEN CLARENCE-SMITH
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
12,023,315Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis202411,752,141Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis202311,389,420Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to DAS MG INC (3)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to SOMERSET THERAPEUTICS LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DAS MG INC | 3 | 2022–2024 |
| SOMERSET THERAPEUTICS LLC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2022–2024 |